๐Ÿ•ต๏ธ Xilio Therapeutics, Inc. ($XLO)

SEC insider & ownership activity, last 12 months ยท CIK 1840233 ยท every row links its SEC filing

Over the last 12 months insiders sold $6K against $2.0M of open-market buying. Gilead Sciences, Inc. bought $2.0M in discretionary trades (Feb). One red-flag 8-K in the window: Delisting notice (3.01), Oct 2, 2025.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net -$6K Mar 2026: net +$44K Mar 2026: net +$44K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $2.0M (2 lots) ยท 2 sellers, $6K (2 lots)

InsiderBuysBoughtSellsSoldLast
Gilead Sciences, Inc.1$2.0M 0โ€“Feb 13, 2026
Shannon James Samuel1$44K 0โ€“Mar 26, 2026
Frankenfield Christopher James0โ€“ 1$5KJan 2, 2026
Kevin M. Brennan0โ€“ 1$1KJan 2, 2026

5%+ holders

HolderStakeClassScheduleEvent
Gilead Sciences, Inc. 19.9% 13GFeb 12, 2026 filing โ†—
BCLS II Equity Opportunities, LP 10.0% 13GMay 15, 2026 filing โ†—
Coastlands Capital LP 10.0% 13GDec 11, 2025 filing โ†—
Coastlands Capital Partners LP 10.0% 13GDec 11, 2025 filing โ†—
Coastlands Capital GP LLC 10.0% 13GDec 11, 2025 filing โ†—
Coastlands Capital LLC 10.0% 13GDec 11, 2025 filing โ†—
Matthew D. Perry 10.0% 13GDec 11, 2025 filing โ†—
Orbimed Advisors LLC 10.0% 13GMay 15, 2026 filing โ†—
Sirenia Capital Management LP 9.9% 13GMay 15, 2026 filing โ†—
Alex Silverstein 9.9% 13GMay 15, 2026 filing โ†—
Abbvie Inc. 9.0% 13GFeb 18, 2025 filing โ†—
Stempoint Capital LP 8.4% 13GFeb 17, 2026 filing โ†—
Stempoint Capital Management GP LLC 8.4% 13GFeb 17, 2026 filing โ†—
Michelle Ross 8.4% 13GFeb 17, 2026 filing โ†—
Orbimed Capital GP X LLC 7.5% 13GMay 15, 2026 filing โ†—
Frazier Life Sciences Public Fund, L.P. 6.7% 13GFeb 13, 2026 filing โ†—
Fhmlsp, L.P. 6.7% 13GFeb 13, 2026 filing โ†—
Fhmlsp, L.L.C. 6.7% 13GFeb 13, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Jun 10, 2026 filing โ†—
Shareholder vote (5.07)Jun 10, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 10, 2026 filing โ†—
Earnings (2.02)May 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 12, 2026 filing โ†—
Officer/director changes (5.02)Apr 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 15, 2026 filing โ†—
Earnings (2.02)Mar 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 23, 2026 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Mar 12, 2026 filing โ†—
Charter/bylaw changes (5.03)Mar 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 12, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 9, 2026 filing โ†—
Shareholder vote (5.07)Feb 23, 2026 filing โ†—
Material agreement (1.01)Feb 11, 2026 filing โ†—
Reg FD disclosure (7.01)Feb 11, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 11, 2026 filing โ†—
Earnings (2.02)Jan 6, 2026 filing โ†—
Officer/director changes (5.02)Jan 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 6, 2026 filing โ†—
Reg FD disclosure (7.01)Jan 5, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 5, 2026 filing โ†—
Officer/director changes (5.02)Nov 21, 2025 filing โ†—
Shareholder vote (5.07)Nov 21, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 21, 2025 filing โ†—
Earnings (2.02)Nov 13, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 7, 2025 filing โ†—
Delisting notice (3.01)Oct 2, 2025 filing โ†—